HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

LovelySkin: Skin-care company founded by dermatologist Joel Schlessinger, M.D., president of the American Society of Cosmetic Dermatology and Aesthetic Surgery, announces launch of FixMySkin line "aimed at men with skin-care concerns such as acne and poor skin texture." Schlessinger states: "I have long known that men are the underserved in the skin world. While products abound for women, men oftentimes don't 'connect' with products due to inappropriate fragrances or labeling." FixMySkin products are scent-free and formulated with lower pH levels than most products on the market, pH levels of which range from 3.8 and upward, "which doesn't allow for much exfoliation," according to LovelySkin. Company also is introducing LovelySkin Gel Cleanser for individuals with oily skin, which will join its other products containing amino fruit acids and "wrinkle-fighting" vitamin C to "soothe and hydrate skin while combating the signs of aging." Company's Web site also offers for purchase products "typically available only in a dermatologist or cosmetic surgeon's office" from brands such as Obagi, Peter Thomas Roth, Dr. Brandt, SkinMedica, SkinCeuticals, Murad, LaRoche-Posey, theBalm and RevaleSkin...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014982

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel